SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-021346
Filing Date
2019-01-30
Accepted
2019-01-29 21:00:03
Documents
5
Period of Report
2019-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d673952d8k.htm 8-K 20703
2 EX-4.1 d673952dex41.htm EX-4.1 55093
3 EX-4.2 d673952dex42.htm EX-4.2 55594
4 EX-10.1 d673952dex101.htm EX-10.1 67026
5 GRAPHIC g673952g0130025100750.jpg GRAPHIC 2483
  Complete submission text file 0001193125-19-021346.txt   203297
Mailing Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362
Business Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362 (818) 629-2256
Sienna Biopharmaceuticals, Inc. (Filer) CIK: 0001656328 (see all company filings)

IRS No.: 273364627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38155 | Film No.: 19550149
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1